Year: 2022

New NXP Analog Front-End Enables the Software-Defined Factory NXP Semiconductors announced its new NXP analog front-end (N-AFE) family for high-precision data acquisition and condition monitoring systems for factory automation. Designed as software-configurable universal analog input devices, the new N-AFE family helps enable the software-defined factory, making it easier for operators to configure a smart factory and adjust settings based on shifting market needs.Industry’s most flexible analog front-end architecture with software-configurable universal analog inputsImproves factory productivity and product quality with enhanced conversion accuracy, precision, and speed Reduces factory downtime with advanced diagnostics for predictive maintenance and anomaly detectionMUNICH, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) —...

SINGAPORE, Nov. 14, 2022 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the U.S. market opens on November 23, 2022. UP Fintech’s management will hold an earnings conference call at 8:00 AM on November 23, 2022, U.S. Eastern Time (9:00 PM on November 23, 2022 Singapore/Hong Kong Time). Conference Call Information: All participants wishing to attend the call must preregister online before they may receive the dial-in numbers. Preregistration may require a few minutes to complete. Preregistration Information: Please note that all participants will need to pre-register for the conference call, using the link: https://register.vevent.com/register/BId7e38763e6214ae9954a24e40e8564f5 It...

Municipality Finance PlcStock exchange release 14 November 2022 at 10.00am (EET) Municipality Finance issues EUR 10 million notes and a GBP 50 million tap to a benchmark under its MTN programme On 15 November 2022 Municipality Finance Plc issues EUR 10 million notes and a new tranche in an amount of GBP 50 million to an existing benchmark issued on 17 March 2021. The notes are issued under MuniFin’s EUR 45 billion programme for the issuance of debt instruments. The offering circular, the supplemental offering circular and the final terms of notes are available in English on the company’s website at www.munifin.fi/investor-relations. MuniFin has applied for the notes to be admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. The public trading is expected to commence on 15 November 2022. The existing...

STMicroelectronics showcases technology for smarter mobility, energy efficiency, and industrial applications at electronica 2022Electrification solutions and advanced digitalization systems suit more affordable EVs with greater range and new levels of performance and safety among smart mobility highlights Broad range of energy efficiency demos across the full range of applications highlight how the company helps customers do more with less Industrial AI demos show how to easily combine Artificial Intelligence/Machine Learning approaches with digitalization and secure connectivity to expand Factory Automation winsGeneva, Switzerland, November 14, 2022 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, will exhibit and present innovative technology at electronica...

Now Available in Europe, parts of the Middle East, Asia, Latin America, and AfricaLumiraDx HbA1c Test LumiraDx Rapid Microfluidic Immunoassay HbA1c Test and Point of Care PlatformEarly customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly half are undiagnosed1 The LumiraDx HbA1c test is designed to address the growing clinical need for accessible and reliable HbA1c testing in community-based healthcare settings such as primary care, diabetes clinics, rural clinics, retail pharmacy & other decentralised healthcare settings The actively controlled microfluidic immunoassay is run on the highly portable LumiraDx Platform and designed for near-patient testing with connected results in under...